BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37013781)

  • 1. Oxytocin receptor (OXTR) is a risk gene for polycystic ovarian syndrome.
    Amin M; Horst N; Wu R; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2634-2639. PubMed ID: 37013781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
    Amin M; Gragnoli C
    J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Risk Variants in the Oxytocin Receptor Gene (
    Amin M; Wu R; Gragnoli C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mineralocorticoid receptor gene (NR3C2) is linked to and associated with polycystic ovarian syndrome in Italian families.
    Amin M; Perrelli M; Wu R; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):942-948. PubMed ID: 36808340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The melatonin receptor genes are linked and associated with the risk of polycystic ovary syndrome.
    Postolache TT; Al Tinawi QM; Gragnoli C
    J Ovarian Res; 2024 Jan; 17(1):17. PubMed ID: 38217063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide linkage and association study identifies novel genes and pathways implicated in polycystic ovarian syndrome.
    Amin M; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3719-3732. PubMed ID: 37140321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
    Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCOS in adolescence and type 2 diabetes.
    Carreau AM; Baillargeon JP
    Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucocorticoid receptor gene (NR3C1) is linked to and associated with polycystic ovarian syndrome in Italian families.
    Syed S; Gragnoli C
    J Ovarian Res; 2024 Jan; 17(1):13. PubMed ID: 38217051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel linkage and association of TCF7L2 variants with PCOS in Italian families.
    Amin M; Del Bosque-Plata L; Gragnoli C
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7346-7351. PubMed ID: 37606143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
    Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
    Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.
    Saxena R; Welt CK
    Acta Diabetol; 2013 Jun; 50(3):451-7. PubMed ID: 22389004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.